Abstract
Methylenetetrahydrofolate reductase (MTHFR) mutations have been linked to many diseases. Evidence has been provided to prove that we need to perform pharmacogenetic studies regarding the prevalence of MTHFR mutations and diseases, risks, and the impact on folate requirement in general, but little has been published about Puerto Ricans. A multi center cross-sectional retrospective review study or a prospective pharmacogenetic study of valid genotypes and phenotypes of MTHFR mutations within the different populations of Puerto Ricans and Hispanics are recommended, because differences within them and within the general population are expected.
Author contributions: The author has accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
References
1. Stanley J, Garet E. Methylenetetrahydrofolate reductase deficiencies. https://www.douadweb.depauw.edu/$1-cfornari/dishen/webpage/index.htm. Accessed in December 2016.Search in Google Scholar
2. Marini NJ, Gin J, Ziegle J, Keho KH, Ginzinger D, Gilbert DA, et al. The prevalence of folate-remedial MTHFR enzyme variants in humans. Proc Natl Acad Sci USA 2008;105:8055–60.10.1073/pnas.0802813105Search in Google Scholar
3. Ayala-Rivera MA, Renta J, Garcia I, Garcia L, de La Vega A, Santiago-Borrero PJ, et al. Prevalence of common mutations of the MTHFR gene in a Puerto Rican population. Genet Med 1999;1:72 (abstract 112).10.1097/00125817-199901000-00123Search in Google Scholar
4. McAdrew PE, Brandt JT, Pearl DK, Prior TW. The incidence of the gene for thermolabile methylenetetrahydrofolate reductasa in African Americans. Thromb Res 1996;83:195–8.10.1016/0049-3848(96)00121-1Search in Google Scholar
5. Jiménez-Ramírez FJ, Castro LM, Ortiz C, Concepción J, Renta JY, Morales-Borges RH, et al. Role of treatment-modifying MTHFR 677C>T and 1298A>C polymorphisms in metformin-treated type-2 diabetes mellitus Puerto Rican patients with peripheral neuropathy: a pilot pharmacogenetic study. Drug Metab Pers Ther 2017;32:23–32.Search in Google Scholar
6. Morales-Borges RH. Prevalence of MTHFR C677T and A1298C mutations and thrombophilia in Puerto Rico. J Blood Disorders Transf 2014;5:213.Search in Google Scholar
7. Claudio-Campos K, Orengo-Mercado C, Renta JY, Peguero M, García R, Hernández G, et al. Pharmacogenetics of healthy volunteers in Puerto Rico. Drug Metab Pers Ther 2015;30: 239–49.10.1515/dmpt-2015-0021Search in Google Scholar PubMed PubMed Central
8. Balley LB, Gregory JF. Polymorphism of methynenetetrahydrofolate reductasa and other enzymes: metabolic significance, risks and impact on folate requirement. J Nutr 1999;129:919–22.10.1093/jn/129.5.919Search in Google Scholar PubMed
9. Jarjour RA, Ammar S, Majdalawi R. Frequency of three prothrombotic polymorphisms among Syrian population: factor V G1691A, prothrombin G20210 and methylenetetrahydrofolate reductasa C677T. Ann Hum Biol 2015;10:1–4.10.3109/03014460.2015.1119308Search in Google Scholar PubMed
10. Wang X, Fu J, Li O, Zeng D. Geographical and ethnic distributions of the MTHFR C677T, A1298C and MTRR A66G gene polymorphisms in Chinese populations: a meta-analysis. PLoS One 2016;11:e0152414.10.1371/journal.pone.0152414Search in Google Scholar PubMed PubMed Central
11. Jacques PF, Bostom AG, William RR, Ellison RC, Eckfeldt JH, Rosenberg IH, et al. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 1996;93:7–9.10.1161/01.CIR.93.1.7Search in Google Scholar PubMed
12. Deloughery TG, Evans A, Sadeghi A, McWilliams J, Henner WD, Taylor LM, et al. Common mutation in methylenetetrahydrofolate reductase. Circulation 1996;94:3074–8.10.1161/01.CIR.94.12.3074Search in Google Scholar PubMed
13. Perez AB, D’Almeida V, Vergani N, de Oliveira AC, de Lima FT, Brunoni D. Methylenetetrahydrofolate reductase (MTHFR): incidence of mutations C677T and A1298C in Brazilian population and its correlation with plasma homocysteine levels in spina bifida. Am J Med Genet A 2003;119A:20–5.10.1002/ajmg.a.10059Search in Google Scholar PubMed
14. Varga EA, Sturm AC, Misita CP, Moll S. Cardiology patient pages. Homocysteine and MTHFR mutations: relation to thrombosis and coronary artery disease. Circulation 2005;111:e289–93.10.1161/01.CIR.0000165142.37711.E7Search in Google Scholar PubMed
15. The National Alliance for Thrombosis and Thrombophilia website. Retrieved December 2016, at http://www.nattinfo.org.Search in Google Scholar
16. Hickey SE, Curry CJ, Toriello HV. ACMG Practice Guideline: lack of evidence for MTHFR polymorphism testing. Genet Med 2013;15:153–6.10.1038/gim.2012.165Search in Google Scholar PubMed
17. Liew SC, Gupta ED. Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism: epidemiology, metabolism and the associated diseases. Eur J Med Genet 2015;58:1–10.10.1016/j.ejmg.2014.10.004Search in Google Scholar PubMed
©2017 Walter de Gruyter GmbH, Berlin/Boston
